Female genital neoplasms

PubMed Free Full Text

Ovarian cancer: screening, prevention, diagnosis

Austria

• Wiener klinische Wochenschrift
  • AGO Austria recommendations for genetic testing of patients with ovarian cancer [2015]

Austria, Germany, Switzerland

• Archives of Gynecology and Obstetrics
  • Intergroup-statement: statement of the german ovarian cancer commission, the North-Eastern German Society of gynecological Oncology (NOGGO), AGO Austria and AGO Swiss regarding the use of homologous repair deficiency (HRD) assays in advanced ovarian cancer [2025]
  • Intergroup statement: opportunistic salpingectomy-molecular pathology, clinical outcomes and implications for practice (German Ovarian Cancer Commission, the North-Eastern German Society of Gynecologic Oncology (NOGGO), AGO Austria and AGO Swiss) [2025]

Belgium

• Facts, Views & Vision in ObGyn
  • The rationale of opportunistic bilateral salpingectomies (OBS) during benign gynaecological and obstetric surgery: a consensus text of the Flemish Society of Obstetrics and Gynaecology (VVOG) [2019]

Brazil

• Revista da Associação Médica Brasileira
  • Relapsed ovarian cancer - diagnosis using 18F-FDG PET/CT [2019]

Canada

• Journal of Medical Genetics
  • Practice guidelines for BRCA1/2 tumour testing in ovarian cancer [2022]

Denmark

• International Journal of Cancer
  • Risk of nonovarian cancer in a nationwide-based study of nearly 5000 women with borderline ovarian tumors in Denmark [2023]
  • Pregnancy duration and ovarian cancer risk: A 50-year nationwide cohort study [2022]

Europe

• Annals of Oncology
  • European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer [2022]

• European Menopause and Andropause Society
  • Interventions to reduce the risk of ovarian and fallopian tube cancer: A European Menopause and Andropause Society Postition Statement [2017]

• European Society of Gastrointestinal and Abdominal Radiology
  • Imaging of peritoneal metastases of ovarian and colorectal cancer: joint recommendations of ESGAR, ESUR, PSOGI, and EANM [2024]

• European Society of Urogenital Radiology
  • ESR Essentials: characterisation and staging of adnexal masses with MRI and CT-practice recommendations by ESUR [2024]

• International Journal of Gynecological Cancer
  • Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer [2016]

• Seminars in Oncology
  • Guidance Statement On BRCA1/2 Tumor Testing in Ovarian Cancer Patients [2017]

Europe, United States

• BJS Open
  • Ovarian cancer risk reduction by salpingectomy during non-gynaecological surgery: scoping review [2024]

• Society of Abdominal Radiology
  • Ovarian cancer reporting lexicon for computed tomography (CT) and magnetic resonance (MR) imaging developed by the SAR Uterine and Ovarian Cancer Disease-Focused Panel and the ESUR Female Pelvic Imaging Working Group [2022]

Germany

• PLoS Medicine
  • Ovarian cancer prevention through opportunistic salpingectomy during abdominal surgeries: A cost-effectiveness modeling study [2025]

Gulf Cooperation Council

• BMC Cancer
  • Prevalence of BRCA1 and BRCA2 pathogenic sequence variants in ovarian cancer patients in the Gulf region: the PREDICT study [2021]

Hong Kong

• Centre for Health Protection
  • Recommendations on Prevention and Screening for Ovarian Cancer For Health Professionals [2018]

International

• BMC Cancer
  • Variation in the initial assessment and investigation for ovarian cancer in symptomatic women: a systematic review of international guidelines [2019]

• Cancer Reports
  • Anthropometric factors and the risk of ovarian cancer: A systematic review and meta-analysis [2022]

• Carcinogenesis
  • Urinary biomarkers for the detection of ovarian cancer: a systematic review [2022]
  • Identification of biomarkers for the diagnosis and targets for therapy in patients with clear cell ovarian cancer: a systematic literature review [2022]

• Cochrane Database of Systematic Reviews
  • Menopausal status, ultrasound and biomarker tests in combination for the diagnosis of ovarian cancer in symptomatic women [2022]

• Frontiers in Endocrinology
  • The risk of ovarian cancer in hormone replacement therapy users: a systematic review and meta-analysis [2024]

• International Federation of Gynecology and Obstetrics
  • FIGO position statement on opportunistic salpingectomy as an ovarian cancer prevention strategy [2024]

• Lancet Oncology
  • Ovarian cancer and smoking: individual participant meta-analysis including 28114 women with ovarian cancer from 51 epidemiological studies [2012]

• Virchows Archiv
  • Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria [2016]

Ireland

• Department of Health Ireland
  • Diagnosis and Staging of Patients with Ovarian Cancer

Italy

• Critical Reviews in Oncology/Hematology
  • Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives [2019]

Japan

• Cancer Science
  • Japanese nationwide observational multicenter study of tumor BRCA1/2 variant testing in advanced ovarian cancer [2023]

Netherlands

• Familial Cancer
  • Optimizing the detection of hereditary predisposition in women with epithelial ovarian cancer: nationwide implementation of the Tumor-First workflow [2024]

• Fertility and Sterility
  • Incidence of ovarian cancer after bilateral salpingo-oophorectomy in women with histologically proven endometriosis [2022]

New Zealand

• Best Practice Advocacy Centre New Zealand
  • Ovarian cancer – early detection and referral [2023]

Puerto Rico

• BioMed Research International
  • Ovarian Cancer Screening Practices of Obstetricians and Gynecologists in Puerto Rico [2014]

Republic of Korea

• Cancer Medicine
  • Stratifying the risk of ovarian cancer incidence by histologic subtypes in the Korean Epithelial Ovarian Cancer Study (Ko-EVE) [2023]

• Cancer Science
  • Prevalence and clinical characterization of BRCA1 and BRCA2 mutations in Korean patients with epithelial ovarian cancer [2021]

• Scientific Reports
  • Increased risk of young-onset ovarian cancer in women with non-alcoholic fatty liver disease: A nationwide cohort study of 2.3 million women aged 20-39 years [2025]

Spain

• Sociedad Española de Oncología Médica
  • Recommendations for biomarker testing in epithelial ovarian cancer: a National Consensus Statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology [2018]

Taiwan

• BMC Women's Health
  • Association of pelvic inflammatory disease (PID) with ovarian cancer: a nationwide population-based retrospective cohort study from Taiwan [2021]

• International Journal of Environmental Research and Public Health
  • Different Influences of Endometriosis and Pelvic Inflammatory Disease on the Occurrence of Ovarian Cancer [2021]

United Kingdom

• BJOG: An International Journal of Obstetrics & Gynaecology
  • The detection of germline and somatic BRCA1/2 genetic variants through parallel testing of patients with high-grade serous ovarian cancer: a national retrospective audit [2022]

• BMC Medicine
  • Cost-effectiveness of screening for ovarian cancer amongst postmenopausal women: a model-based economic evaluation [2016]

• Health Technology Assessment
  • Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial [2025]
  • Risk scores to guide referral decisions for people with suspected ovarian cancer in secondary care: a systematic review and cost-effectiveness analysis [2018]

• Journal of Medical Genetics
  • The avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance programme for women with pathogenic germline variants in BRCA1 and BRCA2 [2023]

• National Institute for Health and Care Excellence
  • Ovarian cancer: identifying and managing familial and genetic risk [2024]
  • Tests in secondary care to identify people at high risk of ovarian cancer [2017]

• Royal College of Obstetricians and Gynaecologists
  • Risk-Reducing Salpingo-Oophorectomy and the Use of Hormone Replacement Therapy Below the Age of Natural Menopause [2021]

• UK National Screening Committee
  • Ovarian cancer

United States

• Agency for Healthcare Research and Quality
  • Screening for Ovarian Cancer [2018]

• American College of Obstetricians and Gynecologists
  • Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention [2019]
  • The Role of the Obstetrician-Gynecologist in the Early Detection of Epithelial Ovarian Cancer in Women at Average Risk [2017]

• American College of Radiology
  • Staging and Follow-Up of Ovarian Cancer
  • Ovarian Cancer Screening

• American Society of Clinical Oncology
  • Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline [2020]

• BMJ Quality & Safety
  • When evidence says no: gynaecologists’ reasons for (not) recommending ineffective ovarian cancer screening [2020]

• Clinical Journal of Oncology Nursing
  • Ovarian Cancer Symptom Clusters: Use of the NIH Symptom Science Model for Precision in Symptom Recognition and Management [2022]

• Environmental Health Perspectives
  • Outdoor Air Pollution Exposure and Ovarian Cancer Incidence in a United States-Wide Prospective Cohort Study [2024]

• International Journal of Gynecological Cancer
  • Temporal trends of healthcare system use between symptomatic presentation and ovarian cancer diagnosis in the United States [2022]

• JCO Oncology Practice
  • Risk-Reducing Bilateral Salpingo-Oophorectomy for Ovarian Cancer: A Review and Clinical Guide for Hereditary Predisposition Genes [2022]

• Society of Gynecologic Oncology
  • Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer [2015]
  • SGO Clinical Practice Statement: Genetic Testing for Ovarian Cancer [2014]
  • SGO Clinical Practice Statement: Salpingectomy for Ovarian Cancer Prevention [2013]

• U.S. Preventive Services Task Force
  • Ovarian Cancer: Screening [2018]

{Related topics}

• Topic
  • Ovarian cancer